WILHELMUS CM GROENHUYSEN Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILHELMUS CM GROENHUYSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of WILHELMUS CM GROENHUYSEN for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 35,000 | 120,400 | 334,663 | |
| Jan 28 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 49.20 | 35,000 | 1,722,000 | 37,149 | 72.1 K to 37.1 K (-48.51 %) |
| Jan 28 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 35,000 | 120,400 | 72,149 | 37.1 K to 72.1 K (+94.22 %) |
| Jan 25 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 35,000 | 120,400 | 369,663 | |
| Jan 25 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 47.35 | 35,000 | 1,657,250 | 37,149 | 72.1 K to 37.1 K (-48.51 %) |
| Jan 25 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 35,000 | 120,400 | 72,149 | 37.1 K to 72.1 K (+94.22 %) |
| Jan 22 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 30,000 | 103,200 | 404,663 | |
| Jan 22 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 45.90 | 30,000 | 1,376,910 | 37,149 | 67.1 K to 37.1 K (-44.68 %) |
| Jan 22 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 30,000 | 103,200 | 67,149 | 37.1 K to 67.1 K (+80.76 %) |
| Jan 16 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 30,000 | 103,200 | 434,663 | |
| Jan 16 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 44.20 | 30,000 | 1,326,000 | 37,149 | 67.1 K to 37.1 K (-44.68 %) |
| Jan 16 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 30,000 | 103,200 | 67,149 | 37.1 K to 67.1 K (+80.76 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 30,000 | 103,200 | 464,663 | |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 42.35 | 30,000 | 1,270,500 | 37,149 | 67.1 K to 37.1 K (-44.68 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 30,000 | 103,200 | 67,149 | 37.1 K to 67.1 K (+80.76 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 27.20 | 25 | 680 | 37,149 | 37.1 K to 37.1 K (+0.07 %) |